About Contact Us Careers
Sign In

Germ Cell Tumor Market - Top Companies and Manufacturers

  • Report ID: 5255
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Germ Cell Tumor Market

    • Eli Lilly and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BioNTech SE
    • ImmunoGen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Accord Healthcare Limited
    • Sandoz International GmbH
    • Lundbeck A/S
    • Pfizer Inc.
    • Merck & Co.
    • Kyowa Hakko Kirin Co., Ltd.
    • Baxter International Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • Immunogen Inc. announced that the US Food and Drug Administration has granted an accelerated approval for ELAHERETM for the treatment of adult patients with folate receptor alpha positive, platinum resistant epithelial ovarian fallopian tube or primary peritoneal cancer who have received one to three prior systemic therapy regimens.
     
  • BioNTech SE reported data from its ongoing first-in-human Phase 1/2 study evaluating the safety and preliminary efficacy of the company's new CAR-T cell therapy candidate, BNT211, in patients with advanced solid tumours. Preliminary results showed an encouraging safety profile and antitumor activity in patients with testicular cancer at the first dose levels of BNT211 evaluated.

Author Credits:  Radhika Pawar


  • Report ID: 5255
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of germ cell tumor is evaluated at USD 14.29 billion.

The germ cell tumor market size was valued at USD 13.87 billion in 2024 and is set to exceed USD 22.52 billion by 2037, registering over 3.8% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of germ cell tumor, the growing geriatric population will drive the market growth.

North America industry is anticipated to dominate majority revenue share of 35% by 2037, backed by expansion in R&D in the region.

The major players in the market include Eli Lilly and Company, BioNTech SE, ImmunoGen Inc., Teva Pharmaceutical Industries Ltd., Accord Healthcare Limited, Sandoz International GmbH, Lundbeck A/S, Pfizer Inc., Merck & Co., Kyowa Hakko Kirin Co., Ltd., Baxter International Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample